Skip to main content
. 2018 Feb 22;7(1):87–120. doi: 10.1007/s40121-018-0188-z

Fig. 3.

Fig. 3

A snapshot of monoclonal antibodies to prevent RSVH in preclinical and clinical development worldwide. Adapted from the PATH (formerly the Program for Appropriate Technology in Health) [143]